6 studies found for:    tocagen
Show Display Options
RSS Create an RSS feed from your search for:
tocagen
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care
Condition: Newly Diagnosed High Grade Glioma (HGG)
Interventions: Biological: Toca 511;   Drug: Toca FC
2 Recruiting P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Biological: Toca 511;   Drug: Toca FC;   Drug: Lomustine;   Drug: Temozolomide;   Biological: Bevacizumab
3 Recruiting A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Solid Tumors
Conditions: Metastatic Colorectal Cancer;   Metastatic Renal Cell Carcinoma;   Metastatic Melanoma;   Brain Metastasis;   Locally Advanced or Metastatic Pancreatic Cancer;   Locally Advanced or Metastatic Breast Cancer
Interventions: Biological: Toca 511;   Drug: Toca FC
4 Active, not recruiting Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
5 Active, not recruiting Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
6 Active, not recruiting A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
Conditions: Glioblastoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Interventions: Biological: Toca 511;   Drug: 5-FC

Indicates status has not been verified in more than two years